Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.
Front Immunol. 2023 Jan 5;13:1010105. doi: 10.3389/fimmu.2022.1010105. eCollection 2022.
Front Immunol. 2023.
PMID: 36685521
Free PMC article.